PubMed

Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers.

Luber A, Condoluci D, Slowinski P, Andrews M, Olson K, Peloquin C, Pappa K, Pakes G; for the COL104422 Study Team.

HIV Med. 2009 Oct 23. [Epub ahead of print]PMID: 19863619 [PubMed - as supplied by publisher]Related articles

CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load.

Condoluci DV, Andrews M, Luber AD.

AIDS Read. 2008 Aug;18(8):410-2.PMID: 18770899 [PubMed - indexed for MEDLINE]Related articles

Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers.

Luber AD, Brower R, Kim D, Silverman R, Peloquin CA, Frank I.

HIV Med. 2007 Oct;8(7):457-64.PMID: 17760738 [PubMed - indexed for MEDLINE]Related articles

Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers.

Ruane PJ, Luber AD, Wire MB, Lou Y, Shelton MJ, Lancaster CT, Pappa KA; COL10053 Study Team.

Antimicrob Agents Chemother. 2007 Feb;51(2):560-5. Epub 2006 Nov 6.PMID: 17088488 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic barriers to resistance and impact on clinical response.

Luber AD.

MedGenMed. 2005 Jul 7;7(3):69. Review.PMID: 16369295 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of acid-reducing agents in protease inhibitor-based HAART and the potential for negative treatment outcomes.

Luber AD.

AIDS Read. 2005 Dec;15(12):692-5, 698-700.PMID: 16355599 [PubMed - indexed for MEDLINE]Related articles

Treatment strategies for highly treatment-experienced HIV-infected patients.

Luber AD.

Expert Rev Anti Infect Ther. 2005 Oct;3(5):815-23. Review.PMID: 16207173 [PubMed - indexed for MEDLINE]Related articles

Genetic barriers to resistance and impact on clinical response.

Luber AD.

J Int AIDS Soc. 2005 Jul 7;7(3):69.PMID: 19825134 [PubMed - in process]Free article

K65R-associated virologic failure in HIV-infected patients receiving tenofovir-containing triple nucleoside/nucleotide reverse transcriptase inhibitor regimens.

Ruane PJ, Luber AD.

MedGenMed. 2004 Apr 6;6(2):31. Review.PMID: 15266257 [PubMed - indexed for MEDLINE]Related articlesFree article

Enfuvirtide.

Lalezari JP, Luber AD.

Drugs Today (Barc). 2004 Mar;40(3):259-69. Review.PMID: 15148534 [PubMed - indexed for MEDLINE]Related articles

Standard methods to measure HIV drug concentrations.

Luber AD, Merry C.

Lancet. 2001 Sep 15;358(9285):930. No abstract available. PMID: 11575381 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus.

Becker S, Fisher A, Flexner C, Gerber JG, Haubrich R, Kashuba AD, Luber AD, Piscitelli SC.

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):210-1. No abstract available. PMID: 11404545 [PubMed - indexed for MEDLINE]Related articles

Risk factors for amphotericin B-induced nephrotoxicity.

Luber AD, Maa L, Lam M, Guglielmo BJ.

J Antimicrob Chemother. 1999 Feb;43(2):267-71.PMID: 11252333 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral therapy for pregnant HIV-infected women.

Luber AD, Dong BJ.

Ann Intern Med. 2000 Mar 21;132(6):509. No abstract available. PMID: 10733458 [PubMed - indexed for MEDLINE]Related articlesFree article

Ceftriaxone therapy for staphylococcal osteomyelitis: a review.

Guglielmo BJ, Luber AD, Paletta D Jr, Jacobs RA.

Clin Infect Dis. 2000 Jan;30(1):205-7.PMID: 10619757 [PubMed - indexed for MEDLINE]Related articles

Prevention of adverse events in hospitalized patients using an antimicrobial review program.

Guglielmo BJ, Luber AD, Corelli RL, Flaherty JF, Jacobs RA.

West J Med. 1999 Sep;171(3):159-62.PMID: 10560287 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypothermia following the intravenous administration of amphotericin B.

Barlows TG 3rd, Luber AD, Jacobs RA, Guglielmo BJ.

Clin Infect Dis. 1996 Nov;23(5):1187-8. No abstract available. PMID: 8922832 [PubMed - indexed for MEDLINE]Related articles

Famciclovir for treatment of herpesvirus infections.

Luber AD, Flaherty JF Jr.

Ann Pharmacother. 1996 Sep;30(9):978-85. Review.PMID: 8876860 [PubMed - indexed for MEDLINE]Related articles

Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci.

Luber AD, Jacobs RA, Jordan M, Guglielmo BJ.

J Infect Dis. 1996 May;173(5):1292-4. No abstract available. PMID: 8627091 [PubMed - indexed for MEDLINE]Related articles